In response:

American Journal of Surgical Pathology

Volumn 34, Issue 6, 2010, Pages 914-

  Lloyd, Ricardo V ^a   Erickson, Lori A ^a   Asioli, Sofia ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953033200     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181d85d94     Document Type: Letter

References (8)

1. Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol. 2006;17:1-18.
2. Apel RL, Asa SL, LiVolsi VA. Papillary Hurtlhe cell carcinoma with lymphocytic stroma. "Warthin-like tumor" of the thyroid. Am J Surg Pathol. 1995;19:810-814.
3. Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44-52.
4. Kakudo K, Tan W, Ito I, et al. Papillary carcinoma of the thyroid in Japan: subclassification of low risk group. J Clin Pathol. 2004;57:1041-1046.
5. Motosugi U, Murata S, Nagata K, et al. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy. Thyroid. 2009;19:535-537.
6. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol. 2004;17:1045-1050.
7. Rosai J, Carcangui ML, DeLellis RA. Tumors of the Thyroid Gland. Atlas of Tumor Pathology. Third Series. Fascicle 5. Washington, DC: Armed Forces Institute of Pathology; 1992.
8. Tang W, Nakamura Y, Zuo H, et al. Differentiation, proliferation and retinoid receptor of papillary carcinoma of the thyroid. Path Internat. 2003;53:204-213.